COMP <GO>
ANGI vs CRTO // REVENUE GROWTH (YOY)
Angi Inc. (Class A) (NASDAQ) VS. Criteo S.A. (NASDAQ) • 15-METRIC TALLY: ANGI 2
— CRTO 7
▲ REVENUE GROWTH (YOY) LEADER: CRTO
LAST: $6.02 (+1.01%) • MKT CAP: $244.1M
revenue-growth
-13.00%
LAST: $14.89 (+2.97%) • MKT CAP: $729.6M
revenue-growth
0.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANGI VS. CRTO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANGI | CRTO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 95.40% | 54.00% | +41.40 | ANGI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.60% | 19.80% | -15.20 | CRTO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 3.8x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 6.30% | 10.40% | -4.10 | CRTO | /operating-margins <GO> |
| Net Profit Margin | 4.30% | 7.70% | -3.40 | CRTO | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | -13.00% | 0.60% | -13.60 | CRTO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.14 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | CRTO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.6 | 44.9 | +4.70 | ANGI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 5.2x | 4.6x | +0.60 | CRTO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $244.1M | $729.6M | -$485.4M | CRTO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANGI REV | CRTO REV | ANGI GROSS % | CRTO GROSS % | ANGI FCF | CRTO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.03B | $1.94B | 95.4% | 54.0% | — | $311.2M |
| FY 2024 | $1.19B | $1.93B | 95.1% | 50.8% | — | $258.2M |
| FY 2023 | $1.36B | $1.95B | — | — | — | $224.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANGI // BETA —
CRTO // BETA —